4506

COM:SUMITOMO-PHARMA

Sumitomo Pharma Co., Ltd.

  • Stock

Last Close

593.00

21/11 06:45

Market Cap

162.09B

Beta: -

Volume Today

4.68M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
387.71B
-
371.37B
4.21%
403.20B
8.57%
411.64B
2.09%
466.84B
13.41%
459.27B
1.62%
459.27B
0%
515.95B
12.34%
560.03B
8.54%
560.03B
0%
314.56B
43.83%
cost of revenue
104.12B
-
101.23B
2.78%
104.47B
3.20%
100.08B
4.20%
112.34B
12.26%
113.55B
1.08%
113.55B
0%
137.77B
21.33%
157.13B
14.05%
157.13B
0%
126.58B
19.44%
gross profit
283.59B
-
270.14B
4.74%
298.74B
10.58%
311.57B
4.30%
354.49B
13.78%
345.71B
2.48%
345.71B
0%
378.18B
9.39%
402.91B
6.54%
402.91B
0%
187.98B
53.34%
selling and marketing expenses
28.82B
-
26.96B
6.44%
24.08B
10.69%
37.98B
-
37.36B
-
37.78B
1.12%
general and administrative expenses
183.65B
-
180.44B
1.75%
180.44B
0%
190.37B
5.51%
249.08B
30.84%
249.08B
0%
429.54B
72.45%
selling general and administrative expenses
28.82B
-
26.96B
6.44%
24.08B
10.69%
183.65B
662.64%
180.44B
1.75%
180.44B
0%
190.37B
5.51%
249.08B
30.84%
249.08B
0%
429.54B
72.45%
research and development expenses
69.80B
-
71.30B
2.15%
82.03B
15.05%
80.82B
1.48%
86.93B
7.56%
102.36B
17.76%
102.36B
0%
132.68B
29.62%
94.90B
28.47%
94.90B
0%
112.64B
18.69%
other expenses
-1.60B
-
-1.57B
1.81%
-749M
52.44%
-802M
7.08%
-4.26B
431.05%
5.03B
218.03%
5.03B
0%
-16.10B
420.27%
-1.31B
91.86%
-1.31B
0%
cost and expenses
345.56B
-
348.09B
0.73%
366.27B
5.22%
358.88B
2.02%
378.67B
5.51%
401.38B
6.00%
401.38B
0%
444.73B
10.80%
499.80B
12.38%
499.80B
0%
668.75B
33.80%
operating expenses
241.45B
-
246.86B
2.24%
261.80B
6.05%
258.81B
1.14%
266.32B
2.90%
287.83B
8.08%
287.83B
0%
306.95B
6.64%
342.67B
11.64%
342.67B
0%
542.17B
58.22%
interest expense
1.01B
-
937M
6.95%
919M
1.92%
631M
31.34%
5.74B
809.19%
207M
96.39%
207M
0%
2.59B
1,149.28%
3.05B
17.94%
3.05B
0%
4.28B
40.23%
ebitda
68.41B
-
41.50B
39.33%
55.11B
32.78%
73.59B
33.54%
103.49B
40.63%
79.23B
23.44%
79.23B
0%
103.11B
30.14%
124.36B
20.61%
124.36B
0%
-316.43B
354.45%
operating income
42.14B
-
23.27B
44.77%
36.93B
58.66%
52.76B
42.87%
88.17B
67.12%
57.88B
34.35%
57.88B
0%
71.22B
23.05%
60.23B
15.43%
86.01B
42.79%
-354.19B
511.80%
depreciation and amortization
26.78B
-
19.23B
28.20%
20.27B
5.40%
18.62B
8.13%
12.89B
30.78%
13.98B
8.45%
13.98B
0%
22.67B
62.23%
38.35B
69.14%
38.35B
0%
167.90K
100.00%
total other income expenses net
-7.43B
-
10.48B
240.90%
2.63B
74.91%
-5.55B
311.04%
-3.31B
40.37%
3.77B
214.12%
7.16B
89.77%
23.55B
228.85%
22.99B
2.37%
-3.05B
113.26%
31.08B
1,119.02%
income before tax
34.71B
-
33.76B
2.75%
39.56B
17.20%
47.22B
19.36%
84.87B
79.74%
65.05B
23.35%
65.05B
0%
77.85B
19.69%
82.96B
6.56%
82.96B
0%
-323.11B
489.48%
income tax expense
14.65B
-
18.31B
24.98%
14.86B
18.81%
18.23B
22.63%
31.42B
72.38%
16.42B
47.74%
16.42B
0%
41.02B
149.84%
42.36B
3.26%
42.36B
0%
-8.19B
119.32%
net income
20.06B
-
15.45B
23.00%
24.70B
59.88%
28.99B
17.39%
53.45B
84.36%
48.63B
9.02%
40.75B
16.19%
56.22B
37.95%
56.41B
0.35%
40.60B
28.03%
-314.97B
875.79%
weighted average shs out
397.31M
-
397.31M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0%
397.29M
0.00%
397.29M
0.00%
397.29M
0%
397.29M
0.00%
weighted average shs out dil
397.31M
-
397.31M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0.00%
397.30M
0%
397.29M
0.00%
397.29M
0.00%
397.29M
0%
397.29M
0.00%
eps
50.49
-
38.88
22.99%
62.16
59.88%
78.82
26.80%
134.53
70.68%
122.39
9.02%
122.39
0%
141.50
15.61%
141.99
0.35%
102.19
28.03%
-792.79
875.80%
epsdiluted
50.49
-
38.88
22.99%
62.16
59.88%
78.82
26.80%
134.53
70.68%
122.39
9.02%
122.39
0%
141.50
15.61%
141.99
0.35%
102.19
28.03%
-792.79
875.80%

All numbers in (except ratios and percentages)